Management of advanced supraglottic laryngeal cancer is complex, and there is no consensus strategy.
1-5 The goals of treatment are cure of disease, with preservation of voice, swallowing, and airway function when possible. Since the seminal Veteran’s Affairs Laryngeal Preservation trial,
6 nonsurgical larynx-preserving treatment approaches have been increasingly used, with laryngectomy reserved for salvage of local failure.
7,8 Subsequent trials established the superiority of concurrent chemoradiotherapy over radiation therapy (RT) alone or with induction chemotherapy.
1,9 However, any direct comparisons of concurrent chemoradiotherapy vs surgery have thus far been limited to retrospective studies.
10,11